Assessing lay beliefs about generic medicines: Development of the generic medicines scale

2009 ◽  
Vol 14 (3) ◽  
pp. 311-321 ◽  
Author(s):  
Maria J. Figueiras ◽  
Nuno C. Alves ◽  
Dália Marcelino ◽  
Maria A. Cortes ◽  
John Weinman ◽  
...  
2008 ◽  
Author(s):  
Michaela Huber ◽  
Leaf Van Boven ◽  
Joshua A. Morris

2016 ◽  
Vol 35 (11) ◽  
pp. 1246-1253 ◽  
Author(s):  
Sarah L. E. Colgan ◽  
Kate Faasse ◽  
Jennifer A. Pereira ◽  
Andrew Grey ◽  
Keith J. Petrie

2017 ◽  
Vol 5 (3) ◽  
pp. 1-9
Author(s):  
Priscila Aburachid Cardoso ◽  

2013 ◽  
Vol 1 (3) ◽  
pp. 1-6
Author(s):  
Pankaj Kashyap ◽  
Eshant Duggal ◽  
Parveen Budhwar ◽  
Jitendra Kumar Badjatya

Generic medicines are those whose patent protection has expired, and which may be produced by manufacturers otherthan the innovator company. Use of generic medicines has been increasing in recent years, primarily as a cost savingmeasure in healthcare provision. Generic medicines are typically 20 to 90% cheaper than originator equivalents. Theobjective is to provide a high-level description of what generic medicines are and how they differ, at a regulatory andlegislative level, from originator medicines. It describes the current and historical regulation of medicines in theworld’s two main pharmaceutical markets, in addition to the similarities, as well as the differences, between genericsand their originator equivalents including the reasons for the cost differences seen between originator and genericmedicines. This article refers to the general generic drug approval process in India, USA, and Japan. They havedifferent regulation and approval process. 


Author(s):  
Salmiah Mohd Ali ◽  
Mohamed Mansor Manan ◽  
Mohamed Azmi Hassali ◽  
Yaman Walid Kassab ◽  
Choon Wai Yee ◽  
...  

2021 ◽  
pp. 014616722110241
Author(s):  
Shai Davidai ◽  
Jesse Walker

What do people know about racial disparities in “The American Dream”? Across six studies ( N = 1,761), we find that American participants consistently underestimate the Black–White disparity in economic mobility, believing that poor Black Americans are significantly more likely to move up the economic ladder than they actually are. We find that misperceptions about economic mobility are common among both White and Black respondents, and that this undue optimism about the prospect of mobility for Black Americans results from a narrow focus on the progress toward equality that has already been made. Consequently, making economic racial disparities salient, or merely reflecting on the unique hardships that Black Americans face in the United States, calibrates beliefs about economic mobility. We discuss the importance of these findings for understanding lay beliefs about the socioeconomic system, the denial of systemic racism in society, and support for policies aimed at reducing racial economic disparities.


Author(s):  
Mingyue Zhao ◽  
Lingyi Zhang ◽  
Zhitong Feng ◽  
Yu Fang

The purpose of this study is to investigate physicians’ knowledge, attitudes and practice of generic medicine substitutions in China. We conducted a cross-sectional online questionnaire survey on physicians from secondary or tertiary hospitals in China from 2020 December to 2021 April. Descriptive statistical and ordered logistic regression were used for analysis. A total of 1225 physicians were included in the final analysis, and only 330 (26.94%) of them scored 4 or above in the knowledge part, which means that the physicians have a good knowledge of generic substitutions. Of the total, 586 (47.83%) agreed or strongly agreed that generic drugs could be substituted for originator drugs and 585 (47.75%) always or often prescribed generic medicines. The percentage of physicians with a positive attitude toward or that practice prescribing generic medicine is below 50%, which needs to be improved in China. Physicians’ knowledge, their attitude toward generic substitution, if familiar with the policy of generic substitution, and incentives for prescribing generic medicines are influencing factors for the practice of generic substitution. Our studies show that the practice of generic substitution by physicians could be improved by several measures in China. We suggested that the physicians should be taught more about the bulk-buy policy and the generic-originator equivalence evaluation policy. Moreover, government incentives to promote generic substitution should be established. Our study also suggested that physicians with less working experience and female physicians should learn more about generic substitution.


Sign in / Sign up

Export Citation Format

Share Document